Report ID: 10059318 |
Published Date: 21 Oct 2022 |
Report Format: |
Delivery Timeline: 48-72 Business Hours
The global urinalysis market is expected to intensify at a CAGR of 6% between 2022 and 2030. Target diseases such as urinary tract infections, kidney diseases and diabetes are huge, with millions of cases occurring every year. Urinalysis is used as the main diagnostic tool for the diagnosis and treatment of these diseases. The huge target population base and a large number of unmet clinical needs observed in underdeveloped regions provide a wealth of potential growth opportunities for the market. In order to take advantage of these opportunities, diagnostic tools must be developed that can meet these unmet clinical needs at an affordable price.
In addition, the sedentary lifestyle has exacerbated the popularity of people in many areas. However, the lack of adequate sanitation infrastructure in low-income countries is the main limitation to the use of the latest urinalysis diagnostic tools. Providing fast and accurate diagnosis and improving ease of use are the core strategies adopted by major market players to address unmet clinical needs in these regions.
PRODUCT INFORMATION:
The market is divided into two parts: instruments and consumables according to products. Automatic and semi-automatic biochemical urine analyzers, urine sediment analyzers and micro urine analyzers are the most widely used instruments in the urine analysis market. It is estimated that the technological advancement of instrumentation has promoted the growth of this market segment at a compound annual growth rate of more than 7% during the forecast period. Automatic urine strip readers and automatic urine sediment analyzers, such as UriSed mini and UriSed 2 from 77 Elektronika Kft, represent the most technologically advanced instruments on the market. market. These advancements also provide a single-level access to the results of the entire hospital.
APPLICATION INFORMATION:
Urinalysis tests are used as first-line diagnostic tools for the diagnosis of various metabolic abnormalities and UTI. Urinalysis is also used as a disease management tool to treat chronic diseases such as diabetes, chronic kidney disease (CKD) and bladder cancer.
The prevalence of target diseases such as diabetes, kidney disease and urinary tract infections is increasing. (UTI) and the introduction of technologically advanced, fast, non-invasive and easy-to-use urinalysis tools are estimated to be the main driving forces for the growth of this market. The market share exceeded 25% in 2020, mainly due to the high prevalence of hospital-acquired urinary tract infections, especially in women, and the effective diagnosis of urinalysis.
END USE INFORMATION:
The clinical laboratory department is the largest end-use department, accounting for more than 30% of the market share in 2020, and its dominance is expected to continue into the forecast period. The large number of procedures associated with these institutions is the main reason for their high percentage. It is expected that the increasing trend of using automation in urinalysis diagnosis will provide a supplementary force for the growth of bedside care and self-assessment based on urinalysis equipment. Due to the above-mentioned factors, the field of home care is expected to see significant growth in the next ten years.
REGIONAL INFORMATION:
North America dominated the entire urine analysis market in 2020. The main drivers of the identified huge market share include the presence of major market players in the region, such as Alere, Inc., Siemens Healthcare, Bio-Rad and Beckman Coulter. In addition, the introduction of automated urine sediment analyzers such as digital flow morphology (digital imaging) and fluorescence flow cytometry, as well as the high health care expenditure in the region, which accounts for about 14% of GDP, are the reasons for the high health care expenditure.
The growth potential of this market. It is expected to witness the fastest growth during the forecast period with a compound annual growth rate of about 9%. The increasing penetration of advanced urine analyzers, the presence of local urine analyzer manufacturers (such as Mindray and Urit Medical), and a large target population base with unmet clinical needs are expected to strengthen market growth during the forecast period.
COMPETITIVE MARKET SHARE INFORMATION:
Global urine analysis market participants include Alere, Inc., ARKRAY, Inc., Bio-Rad, Mindray, Roche Diagnostics, Siemens Healthcare and Sysmex. Mergers and acquisitions aimed at covering a broad distribution area and focusing on the development of new products are the key strategies implemented by these players. In addition, the investment in improved and automated diagnostic tools for urinalysis is a transformative decision for this product. Developers and end users, such as hospitals and clinical laboratories
"
?
Why Choose Kenneth Research ?
-
Insight with Impact : We don’t just gather data — we uncover stories, trends, and opportunities that fuel business growth.
-
Experts Who Get It : Our team speaks your industry’s language and knows what really matters to your customers and market.
-
Custom-Built for You : Forget one-size-fits-all. We craft research and consulting solutions as unique as your business vision.
-
Partners, Not Just Providers : We work with you, not for you — collaborating closely to turn insights into smart, strategic moves.
-
Results That Speak : Our work powers brands, startups, and industry leaders alike — with a track record of ideas that work in the real world.
Report ID: 10059318 |
Published Date: 21 Oct 2022 |
Report Format: |
Delivery Timeline: 48-72 Business Hours
